Clinical Trial Update: A Study of OV101 in Individuals With Angelman Syndrome (AS) [Phase 3]

View source ↗

Summary

Phase 3 trial of OV101 in Angelman Syndrome has been completed with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angelman Syndrome

Drugs mentioned

• OV101 (ov101)

Snippet

Sponsor: Healx AI | Conditions: Primary Disease or Condition Being Studied: Angelman Syndrome (AS) | Phase 3 | Status: COMPLETED | Results posted: 2024-01-08